Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Dayana Herrera Rios"'
Autor:
Antje Sucker, Iris Helfrich, Luiza Martins Nascentes Melo, Dayana Herrera-Rios, Daniel Hinze, Stefanie Löffek, Irem Oezel, Juliane Klein, Sonia Leonardelli, Isa-Vanessa Westedt, Yahya Al-Matary, Sara Egea-Rodriguez, Alexandra Brenzel, Maja Bau, Eva Hadaschik, Florian Wirsdörfer, Niklas Uhlenbrock, Daniel Rauh, Joanna Poźniak, Florian Rambow, Jean-Christophe Marine, Maike Effern, Nicole Glodde, Jadwiga Jablonska
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 4 (2023)
Background Immune responses against tumors are subject to negative feedback regulation. Immune checkpoint inhibitors (ICIs) blocking Programmed cell death protein 1 (PD-1), a receptor expressed on T cells, or its ligand PD-L1 have significantly impro
Externí odkaz:
https://doaj.org/article/eb05894568da4d9e909a3aa7f4f8edb4
Autor:
Dayana Herrera-Rios, Sadaf S. Mughal, Sarah Teuber-Hanselmann, Daniela Pierscianek, Antje Sucker, Philipp Jansen, Tobias Schimming, Joachim Klode, Julia Reifenberger, Jörg Felsberg, Kathy Keyvani, Benedikt Brors, Ulrich Sure, Guido Reifenberger, Dirk Schadendorf, Iris Helfrich
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
The manifestation of brain metastases in patients with advanced melanoma is a common event that limits patient's survival and quality of life. The immunosuppressive properties of the brain parenchyma are very different compared to the rest of the bod
Externí odkaz:
https://doaj.org/article/d7ca3736e1934324947ac283f37f4b6b
Autor:
Luiza Martins Nascentes Melo, Dayana Herrera-Rios, Daniel Hinze, Stefanie Löffek, Irem Oezel, Roberta Turiello, Juliane Klein, Sonia Leonardelli, Isa-Vanessa Westedt, Yahya Al-Matary, Sara Egea-Rodriguez, Alexandra Brenzel, Maja Bau, Antje Sucker, Eva Hadaschik, Florian Wirsdörfer, Helmut Hanenberg, Niklas Uhlenbrock, Daniel Rauh, Joanna Poźniak, Florian Rambow, Jean-Christophe Marine, Maike Effern, Nicole Glodde, Dirk Schadendorf, Jadwiga Jablonska, Michael Hölzel, Iris Helfrich
BackgroundImmune responses against tumors are subject to negative feedback regulation. Immune checkpoint inhibitors (ICIs) blocking Programmed cell death protein 1 (PD-1), a receptor expressed on T cells, or its ligand PD-L1 have significantly improv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e635e007e7980f60883552af314d2074
https://www.ncbi.nlm.nih.gov/pubmed/37028818
https://www.ncbi.nlm.nih.gov/pubmed/37028818
Autor:
Ulf Dietrich Kahlert, Michael S. Sabel, Dieter Willbold, Jarek Maciaczyk, Marcel A. Kamp, Hans-Jakob Steiger, Katharina Koch, Abigail K. Suwala, Amit Sharma, Rudolf Hartmann, Dayana Herrera Rios
Publikováno v:
Cancers 13(23), 6001-(2021). doi:10.3390/cancers13236001
Cancers, vol 13, iss 23
Cancers
Cancers, Vol 13, Iss 6001, p 6001 (2021)
Cancers; Volume 13; Issue 23; Pages: 6001
Cancers, vol 13, iss 23
Cancers
Cancers, Vol 13, Iss 6001, p 6001 (2021)
Cancers; Volume 13; Issue 23; Pages: 6001
Simple Summary Glioblastoma (GBM) is the most aggressive form of glioma (WHO grade IV), and mounting evidence suggests that glioblastoma stem-like cells (GSCs) play an important role in tumor growth and response to therapy. In the current study, we s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c39e202ff0c8fb8af5d45c011d28f4d
https://juser.fz-juelich.de/record/902967
https://juser.fz-juelich.de/record/902967
Autor:
Karl Köhrer, Jaroslaw Maciaczyk, Philippe Aretz, Ulf Dietrich Kahlert, Guido Reifenberger, Hans-Jakob Steiger, Constanze Uhlmann, Abigail K. Suwala, Isabella Ogorek, Dayana Herrera Rios, Katharina Koch, Jörg Felsberg, René Deenen
Publikováno v:
Oncotarget
Glioblastoma is the most aggressive type of glioma. The Wingless (Wnt) signaling pathway has been shown to promote stem cell properties and resistance to radio- and chemotherapy in glioblastoma. Here, we demonstrate that pharmacological Wnt pathway i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0c80a578d999a410cb217eecb967282
https://doi.org/10.18632/oncotarget.25210
https://doi.org/10.18632/oncotarget.25210
Autor:
Dayana, Herrera-Rios, Sadaf S, Mughal, Sarah, Teuber-Hanselmann, Daniela, Pierscianek, Antje, Sucker, Philipp, Jansen, Tobias, Schimming, Joachim, Klode, Julia, Reifenberger, Jörg, Felsberg, Kathy, Keyvani, Benedikt, Brors, Ulrich, Sure, Guido, Reifenberger, Dirk, Schadendorf, Iris, Helfrich
Publikováno v:
Frontiers in Immunology
The manifestation of brain metastases in patients with advanced melanoma is a common event that limits patient's survival and quality of life. The immunosuppressive properties of the brain parenchyma are very different compared to the rest of the bod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::84003cac6c1092c17c7c89e2a060a724
https://pubmed.ncbi.nlm.nih.gov/32117271
https://pubmed.ncbi.nlm.nih.gov/32117271
Autor:
Abigail K. Suwala, Katharina Koch, Ulf Dietrich Kahlert, Jaroslaw Maciaczyk, Dayana Herrera Rios, Rudolf Hartmann
Publikováno v:
Cancer Research. 77:2496-2496
Glioblastoma (GBM) is the most lethal primary malignant brain tumor with a median survival of less than two years. High levels of therapy resistance, strong cellular invasiveness and rapid cell growth demand aggressive multimodal therapies involving
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f42ecd24f0f065acd40baa2f39dce0e
https://doi.org/10.1158/1538-7445.am2017-2496
https://doi.org/10.1158/1538-7445.am2017-2496